论文部分内容阅读
第3届全国流行性出血热(下称出血热)学术会议于1994年10月8～10日在北京召开。会议分6个专题报告了国内外在出血热基础和临床研究领域中的最新进展。在大会交流的275篇论文中,一些项目达到了国际水平。特别是上海的“沙鼠肾细胞野鼠型单价灭活疫苗”、兰州的“鼠脑纯化野鼠型单价灭活疫苗”、长春的“地鼠肾细胞家鼠型单价灭活疫苗”,近年均获得突破性进展,相继得到卫生部颁发的试生产文号,为出血热的防治提供了
The 3rd National Epidemic Hemorrhagic Fever (Hemorrhagic Fever) Academic Conference was held in Beijing from October 8 to October 10, 1994. The conference featured 6 special reports on the latest developments in the field of basic and clinical research of hemorrhagic fever at home and abroad. Of the 275 papers exchanged at the conference, some of the projects have reached the international level. In particular, Shanghai “gerbil kidney cell wild mouse monovalent inactivated vaccine”, Lanzhou “rat brain purified wild type monovalent inactivated vaccine”, Changchun “hamster kidney cell monovalent inactivated vaccine” in recent years have been Breakthrough progress, have been issued by the Ministry of Health trial production code for the prevention and treatment of hemorrhagic fever provided